A Multicenter Retrospective Analysis of Clinicopathologic Features of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
Conclusion: Although most patients had limited stage, the clinical outcomes of MEITL patients were dismal. While the optimal management of MEITL remains undetermined, achieving CR and consolidative ASCT seem to be essential. In addition, considering the frequent local failure, as well as the CNS relapse, novel therapeutic approaches are required to improve survival.Figure.DisclosuresKim: Mundipharma: Research Funding; Merck: Research Funding; Celgene: Research Funding; Takeda: Research Funding; Roche: Honoraria, Research Funding; Kyowa-Kirin: Research Funding; Eisai: Honoraria, Research Funding; J&J: Research Funding; Celltrion: Honoraria, Research Funding; Novartis: Research Funding.
Source: Blood - Category: Hematology Authors: Yi, J. H., Gyeong-Won, L., Do, Y. R., Jung Yong, H., Suh, C., Choi, Y. S., Lee, S. Y., Sohn, B. S., Kim, B.-S., Kim, S. J., Kim, W.-S. Tags: 624. Hodgkin Lymphoma and T/NK Cell Lymphoma-Clinical Studies: Poster II Source Type: research
More News: Celiac Disease | Chemotherapy | Coeliac Disease | Hodgkin's Disease | Laboratory Medicine | Lymphoma | Merck | Primary CNS Lymphoma | Stem Cell Therapy | Stem Cells | Study | T-cell Lymphoma | Transplants